Drawing for HEMATIDE

USPTO serial 85383694

HEMATIDE

Reviewed by CopyMark Law Group

Status 606
Filing date
Status date
Registration date
—
Examiner
VENGROFF, MARILYN
Law office
INTENT TO USE SECTION

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with HEMATIDE?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Anne Peck

Anne Peck Cooley LLP1299 Pennsylvania Avenue NW, Suite 700Washington, DC 20004UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
005Pharmaceuticals for use in stimulating human blood cell production; pharmaceuticals for the treatment of cancer, anemia, ischemia, myocardial infarction, congestive heart failure, renal failure, anoxia-induced cellular degeneration, hypoxia-induced cellular degeneration and strokeACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Oct 11, 2013TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Sep 23, 2013MAB6ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Sep 23, 2013ABN6ABANDONMENT - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Feb 23, 2013EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Feb 22, 2013EX2GSOU EXTENSION 2 GRANTED—
Feb 21, 2013AITUCASE ASSIGNED TO INTENT TO USE PARALEGAL—
Feb 12, 2013EXT2SOU EXTENSION 2 FILED—
Feb 12, 2013EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Jun 20, 2012EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Jun 18, 2012EX1GSOU EXTENSION 1 GRANTED—
Jun 18, 2012EXT1SOU EXTENSION 1 FILED—
Jun 18, 2012EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Feb 21, 2012NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Dec 27, 2011NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Dec 27, 2011PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Dec 7, 2011NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Nov 18, 2011CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Nov 18, 2011DOCKASSIGNED TO EXAMINER—
Aug 2, 2011NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Aug 1, 2011NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance